# Genetic Testing for Men With Metastatic Prostate Cancer

> **NCT03503097** · — · TERMINATED · sponsor: **University of Washington** · enrollment: 799 (actual)

## Conditions studied

- Metastatic Prostate Carcinoma
- Stage IV Prostate Cancer AJCC v8
- Stage IVB Prostate Cancer AJCC v8

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Genetic Counseling
- **OTHER:** Genetic Testing
- **OTHER:** Laboratory Biomarker Analysis
- **BEHAVIORAL:** Questionnaire

## Key facts

- **NCT ID:** NCT03503097
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-08-21
- **Primary completion:** 2024-08-21
- **Final completion:** 2025-09-17
- **Target enrollment:** 799 (ACTUAL)
- **Why stopped:** Study closed to accrual before meeting enrollment goal due to end of funding.
- **Last updated:** 2025-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03503097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03503097, "Genetic Testing for Men With Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03503097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*